Radiographic progression-free survival in the ACIS trial for prostate cancer

Shai Gilboa; David Bomze; Gal Markel; Tomer Meirson

doi:10.1016/s1470-2045(21)00710-5

Radiographic progression-free survival in the ACIS trial for prostate cancer

Shai Gilboa, David Bomze, Gal Markel, Tomer Meirson

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English
Pages (from-to)	e3
Journal	The Lancet Oncology
Volume	23
Issue number	1
DOIs	https://doi.org/10.1016/s1470-2045(21)00710-5
State	Published - Jan 2022
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/s1470-2045(21)00710-5

Cite this

@article{e1756de3fb214cf39fc157e495af603e,

title = "Radiographic progression-free survival in the ACIS trial for prostate cancer",

author = "Shai Gilboa and David Bomze and Gal Markel and Tomer Meirson",

year = "2022",

month = jan,

doi = "10.1016/s1470-2045(21)00710-5",

language = "אנגלית",

volume = "23",

pages = "e3",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier Ltd.",

number = "1",

}

TY - JOUR

T1 - Radiographic progression-free survival in the ACIS trial for prostate cancer

AU - Gilboa, Shai

AU - Bomze, David

AU - Markel, Gal

AU - Meirson, Tomer

PY - 2022/1

Y1 - 2022/1

UR - http://www.scopus.com/inward/record.url?scp=85121924474&partnerID=8YFLogxK

U2 - 10.1016/s1470-2045(21)00710-5

DO - 10.1016/s1470-2045(21)00710-5

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 34973229

AN - SCOPUS:85121924474

SN - 1470-2045

VL - 23

SP - e3

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 1

ER -

Radiographic progression-free survival in the ACIS trial for prostate cancer

UN SDGs

Access to Document

Other files and links

Cite this